Unknown

Dataset Information

0

Phage therapy for secondary bacterial infections with COVID-19

ABSTRACT: With more than 200 million people affected and 4.5 million deaths so far, the coronavirus disease 2019 (COVID-19) pandemic has become one of the greatest disasters in human history. Secondary bacterial infections (SBIs) are a known complication of viral respiratory infections, and are significantly associated with poorer outcomes in COVID-19 patients despite antibiotic treatments. The increasing antimicrobial resistance (AMR) in bacteria and the decreasing options available in our antimicrobial armory worsen this crisis and call for alternative treatment options. As natural killers of bacteria, phages are recognized as promising alternatives to antibiotics in treating pulmonary bacterial infections, however, little is known about their use for treating SBIs during virus pandemics such as COVID-19. This review highlights the situation of SBIs in COVID-19 patients, and the distinct strengths and limitations of phage therapy for their containment.

SUBMITTER: Wu N 

PROVIDER: S-EPMC8576063 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Phage therapy as a revolutionary medicine against Gram-positive bacterial infections.
| S-EPMC8401357 | biostudies-literature
Unknown Pre-optimized phage therapy on secondary <i>Acinetobacter baumannii</i> infection in four critical COVID-19 patients.
| S-EPMC8032346 | biostudies-literature
Unknown Phage therapy for respiratory infections.
| S-EPMC6226339 | biostudies-literature
Unknown Causes and Consequences of COVID-19-Associated Bacterial Infections.
| S-EPMC8329088 | biostudies-literature
Transcriptomics Heterotypic Influenza Infections Mitigate Susceptibility to Secondary Bacterial Infection
2022-06-27 | GSE206095 | GEO
Unknown The Safety and Efficacy of Phage Therapy for Superficial Bacterial Infections: A Systematic Review.
| S-EPMC7692203 | biostudies-literature
Transcriptomics Impaired antibacterial immune signaling and changes in the lung microbiome precedes secondary bacterial pneumonia in COVID-19
2021-03-03 | GSE168019 | GEO
Unknown Secondary Bacterial Infections Associated with Influenza Pandemics.
| S-EPMC5481322 | biostudies-other
Unknown Increased rates of secondary bacterial infections, including <i>Enterococcus</i> bacteremia, in patients hospitalized with coronavirus disease 2019 (COVID-19).
| S-EPMC8458844 | biostudies-literature
Unknown Characterization of Secondary Bacterial Infections and Antibiotic Use in Mechanically Ventilated Patients With COVID-19 Induced Acute Respiratory Distress Syndrome.
| S-EPMC8358424 | biostudies-literature